Description: QuantRx Biomedical Corporation is engaged in developing and commercializing its miniform pad (PAD)-based products for the over-the-counter markets for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs. It is focused on developing and commercializing genomic diagnostics for the laboratory market, based on its PadKit technology. Its platforms include inSync, Unique, PadKit, and original equipment manufacturer branded over-the-counter and laboratory testing products based on its PAD technology. Its PAD products are based on the non-woven disposable absorbent pad technology, with products for aiding the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, the over-the-counter catamenial markets, and other medical needs, including diagnostic sampling products, which enable self-collection and around the world transport for indications, such as cancers, premature delivery, and genomic testing.
Home Page: www.quantrx.com/index.htm
10190 SW 90th Avenue
Tualatin,
OR
97062
United States
Phone:
212 980 2235
Officers
| Name | Title |
|---|---|
| Dr. Shalom Z. Hirschman M.D. | Chairman, CEO & Principal Accounting Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 1988-05-31 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |